1913–1920

Quantitative Energetics of Metabolism

Contemporary themes

A unifying, quantitative approach to metabolism emerged, linking whole‑body energy expenditure with substrate partitioning and organ‑level energetics across animals and humans. Researchers integrated muscular work, oxygen consumption, basal metabolic rate, and substrate switching, highlighting mitochondria as central hubs that couple energy production to systemic gas transport. Endocrine regulation and lactation‑related metabolic reallocations became central themes, while cross‑species model systems underscored conserved metabolic states across kingdoms, including hepatic processing of bile pigments and bile acids.

• Quantitative energy metabolism and substrate partitioning unify the era’s metabolism work, tying basal metabolic references to fat vs carbohydrate energy tradeoffs across animals and humans and integrating whole‑body energetics with organ-level data[3][10][13][14].
• Cellular energy production and organ metabolism are linked through mitochondria and in vitro cell metabolism studies, connecting mitochondrial function to heart–lung carbohydrate metabolism and systemic gas transport[2][3][10][18].
• Endocrine and reproductive regulation of metabolism emerges as a core theme, detailing how endocrine glands modulate metabolism, and how lactation and mineral exchange reallocate metabolic pathways[7][16][17].
• Model systems spanning actinomycete metabolism, pig endogenous metabolism, and microbial carbohydrate metabolism reveal conserved biochemical pathways and metabolic states across kingdoms: microbial, animal, and cell systems[5][9][12][18].
• Bile- and liver-linked metabolism shows hepatic processing of bile pigments and bile acids as central metabolic routes, highlighting liver physiology and secondary metabolism[8][11].

Influential works

The period established foundational methods and concepts that shaped future metabolic research, including early ergometry and energy‑budget frameworks and the quantification of oxygen transport limits. Basal metabolic rate benchmarks emerged across age, sex, and size, informing nutrition science and metabolic theory. The carbohydrate metabolism studies outlined early oxidation energy yields, laying groundwork for later biochemical metabolism concepts and enabling integration with liver and hepatic metabolism in systemic physiology.

• Muscular work; a metabolic study with special reference to the efficiency of the human body as a machine (1913)[7] introduced quantitative analysis of energy expenditure during muscular work, measuring oxygen use and heat to define metabolic efficiency, shaping early ergometry and energy-budget research.
• The Combinations of Haemoglobin with Oxygen and with Carbon Monoxide. I (1913)[2] systematically quantified oxygen binding and carbon monoxide interaction with haemoglobin, revealing limits of oxygen transport and establishing a metabolic framework for tissue oxygen delivery and respiratory regulation.
• Biometric studies of basal metabolism in man (1919)[4] applied biometric methods to basal metabolic rate, establishing baseline energy expenditure and variability by age, sex, and size, foundational for nutrition science and metabolic theory.
• The metabolism of carbohydrates. Part I (1920)[15] outlined early concepts in carbohydrate oxidation and energy yield, laying groundwork for biochemical metabolism and influencing later nutrition and metabolic physiology.

1921–1942

In Vivo Tumor Metabolism

Contemporary themes

In this era, metabolism research fused in vivo energy measurements with enzymatic and nutritional studies to map energy use in health and cancer. The period foregrounded tumor energy utilization and substrate preferences, particularly carbohydrate metabolism, while examining hormonal and dietary regulation of liver, muscle, and blood glucose homeostasis. Methodological advances in measurement and normalization, along with tissue-scale assays, helped unify energy accounting across tissues and provided a framework for linking thermodynamics to whole-animal metabolism.

• Hormonal and enzymatic regulation of carbohydrate metabolism across liver, muscle and blood sugar homeostasis, integrating insulin signaling, glycogen synthesis and dietary carbohydrate effects on ketosis[4][6][14][15][16][18].
• Enzyme- and tissue-level energy metabolism as core drivers of metabolism: malic dehydrogenase, lactic dehydrogenase, glucose dehydrogenase, and broader tissue metabolism[2][12][13][19].
• Mineral and trace-element homeostasis shapes metabolic pathways: copper and zinc metabolism, calcium/magnesium/phosphorus transport, and iron metabolism[7][8][11][17].
• Bioenergetics and whole-animal energy accounting emerge through measures of heat production and glycogen energetics, linking thermodynamics to metabolism[1][9][16].
• Measurement- and systems-level approaches to metabolism, integrating anatomy, normalization of metabolic results, and tissue-scale assays to study metabolic regulation[1][5][13].

Influential works

The period established tumor metabolism as a distinct focus within biochemistry and physiology, shaping decades of cancer metabolism and nutrition research. Foundational works synthesized tumor energy pathways, nutrient demands, and regulatory aspects, and introduced practical standards such as basal metabolic rate nomograms for clinical use. Collectively, these contributions laid the groundwork for systematic studies of metabolism in health and disease, solidifying the centrality of energy balance in biomedical science.

• The Metabolism of Tumors in the Body (1927)[2] introduced in vivo measurements of tumor energy use, revealing tumor-specific substrate utilization and metabolism rates, and laying the groundwork for decades of cancer metabolism research.
• Observations on the carbohydrate metabolism of tumours (1929)[11] documented altered glycolytic flux and sugar utilization in malignant tissues, providing concrete evidence that carbohydrate pathways are different in tumors and shaping subsequent metabolic cancer studies.
• THE METABOLISM OF TUMOURS (1931)[4] is a comprehensive synthesis of tumor energy pathways, nutrient needs, and regulatory aspects, reinforcing the view that cancer tissue operates with dysregulated, tumor-specific metabolism.
• Metabolism of amino-acids (1935)[13] offers a systematic analysis of amino-acid metabolism and catabolic routes, influencing the biochemistry of protein turnover and nutrition research for years.
• STUDIES OF THE ENERGY OF METABOLISM OF NORMAL INDIVIDUALS: A STANDARD FOR BASAL METABOLISM, WITH A NOMOGRAM FOR CLINICAL APPLICATION (1936)[8] established basal metabolic rate and a practical nomogram, providing a foundational standard for clinical nutrition and metabolic physiology.

1943–1949

Enzymatic Regulation of Metabolism

Contemporary themes

Metabolic regulation during this era is dominated by enzymatic control and organelle localization, shaping tissue-specific flux and turnover. Across tissues, tracer-based approaches reveal unified patterns across nucleic acids, proteins, phosphate dynamics, and xenobiotic metabolism, linking metabolism to growth and external substrates. Endocrine and pharmacologic modulation—steroid handling and drug effects on thyroid function—emerge as key regulators of basal metabolic state.

• Natural Language Processing (NLP) identifies tracer-based flux and turnover as a unifying metabolism pattern across tissues. Evidence spans nucleic acids in liver/hepatoma turnover[6], proteinbound iodine in plasma[5], and phosphate dynamics after insulin[4], plus radiochemical metabolism of fission products/heavy elements[8].
• Natural Language Processing (NLP) highlights that metabolism is sculpted by intracellular enzymatic systems and organelle localization. Exemplars include glyceraldehyde-3-phosphate dehydrogenase from rabbit muscle[16], intracellular fatty acid oxidase structures[15], cytosolic distribution of cytochrome oxidase/succinoxidase[10], and whole-tissue enzymatic rate patterns[19][20].
• Natural Language Processing (NLP) reveals endocrine and pharmacologic control of metabolic state. Estrone metabolism in men[3] illustrates steroid handling, while thyroid modulation by sulfonamides and thioureas[9][12] shows drug-induced shifts in basal metabolism and endocrine function.
• Natural Language Processing (NLP) uncovers xenobiotic/metals metabolism as a distinct paradigm, with biotransformation of americium in rats[2], naphthalene to dihydronaphthalene-1:2-diol[7], and yeast oxybiotin metabolism[18] illustrating cross-species processing of foreign substrates.
• Natural Language Processing (NLP) captures nucleic acid metabolism with growth coupling in liver. Nucleic acids turnover in rat liver and hepatoma related to growth[6], and folic acid production by rat liver in vitro[14] frame metabolism around genetic material and growth-associated biosynthesis.

Influential works

Breakthrough methodological advances, including new methods for calculating metabolic rate with emphasis on protein turnover, enabled refined energy expenditure assessments. Foundational enzymology established the oxidative redox link between malate/isocitrate and pyruvate, clarifying energy flow from glycolysis into the citric acid cycle. Substantial work mapped the distribution of key mitochondrial enzymes in liver and demonstrated iodide's regulatory role on thyroid function, tying mineral balance to metabolic rate and endocrine control.

• New methods for calculating metabolic rate with special reference to protein metabolism (1949)[1] introduced refined experimental procedures and calculations for estimating metabolic rate with a focus on protein turnover, enabling precise energy expenditure assessments. This methodological breakthrough influenced subsequent protein metabolism research.
• THE ENZYMATIC MECHANISM OF OXIDATION-REDUCTIONS BETWEEN MALATE OR ISOCITRATE AND PYRUVATE (1948)[2] demonstrated the enzymatic basis for redox conversions linking malate/isocitrate to pyruvate, clarifying energy flow from glycolysis to the tricarboxylic acid cycle and guiding later metabolic enzymology work.
• THE RENAL REGULATION OF ACID-BASE BALANCE IN MAN. III. THE REABSORPTION AND EXCRETION OF BICARBONATE. (1949)[9] showed how kidney bicarbonate handling maintains systemic acid-base homeostasis, anchoring metabolic regulation in renal physiology and informing subsequent nephrology and metabolic research.
• PLASMA INORGANIC IODIDE AS A HOMEOSTATIC REGULATOR OF THYROID FUNCTION (1948)[10] established iodide as a regulator of thyroid activity, tying trace mineral balance to metabolic rate and endocrine control, shaping later endocrinology and metabolism studies.
• THE DISTRIBUTION OF CYTOCHROME OXIDASE AND SUCCINOXIDASE IN THE CYTOPLASM OF THE MAMMALIAN LIVER CELL (1946)[6] mapped subcellular localization of mitochondrial enzymes, informing understanding of hepatic oxidative metabolism and organelle regulation; foundational for later mitochondrial biology work.

1950–1979

Redox Cofactor Regulation

Contemporary themes

The dominant paradigm linked redox cofactor balance across cytosol and mitochondria to the regulation of energy production, biosynthesis, and detoxification through NAD and NADP pools, constraining gluconeogenesis and lipid handling. The mitochondrion stood as the central energy hub, with oxidative phosphorylation regulated by inorganic phosphate, CoA/Palmitoyl-CoA dynamics, and substrate availability, shaping metabolic flux via PDH control. Across tissues, glucose metabolism and adipose uptake were interrogated with perfused-liver and isolated enzyme models, while microsomal systems defined xenobiotic processing and hepatotoxic pathways, and lipid turnover revealed coordinated remodeling across organs.

• Redox cofactor balance across cytosol and mitochondria acts as a central integrator of hepatic metabolism, modulating energy production, biosynthesis, and detoxification through NAD/NADP pools; shifts observed in NADH/NADPH couplements influence gluconeogenesis and lipid handling[1][5][12].
• A systems view of mitochondria as energy hubs where oxidative phosphorylation is modulated by inorganic phosphate and acceptor systems, cofactor pools, and substrate availability; PDH complex regulation and CoA/Palmitoyl-CoA dynamics shape metabolic flux[6][7][8][19][20].
• Glucose metabolism regulation across liver and peripheral tissues: properties of phosphofructokinase, gluconeogenesis from amino acids in perfused liver, and adipose glucose uptake, highlighting in vitro or perfused-system analyses as a methodological paradigm for metabolic flux control[10][13][16][18].
• Microsomal enzyme systems as models of hepatic metabolism and xenobiotic processing: isolated P-450 preparations and NADPH-dependent reductase underpin drug metabolism, while the hepatic microsomal ethanol-oxidizing system frames oxidation pathways linked to hepatotoxicity[3][9].
• Lipid metabolism and adipose tissue dynamics: rates of long-chain fatty acid oxidation vs synthesis, fatty-acid turnover in adipose tissue in vitro, and mitochondrial lipid intermediates (long-chain acyl-CoA/CoA) illustrate coordinated lipid remodeling across tissues[4][11][14][19].

Influential works

Breakthroughs including the glucose–fatty-acid cycle reframed insulin sensitivity and metabolic syndrome; the demonstration that mitochondria generate reactive oxygen species seeded redox biology across aging, cancer, and mitochondrial disease research. Foundational methodological works on enzyme diagnostics and starvation physiology standardized approaches and shaped clinical and experimental metabolism for decades.

• The Glucose Fatty-Acid Cycle Its Role in Insulin Sensitivity and the Metabolic Disturbances of Diabetes Mellitus (1963) introduced the glucose–fatty acid cycle, formalizing substrate competition between glucose and fatty acids as a determinant of insulin sensitivity and diabetic metabolism. It reshaped metabolic regulation research and guided later work on metabolic syndrome[2].
• The mitochondrial generation of hydrogen peroxide. General properties and effect of hyperbaric oxygen (1973) demonstrated mitochondria as a source of reactive oxygen species, outlining key properties of H2O2 production and how oxygen tension modulates ROS. This work seeded modern redox biology and influenced aging, cancer, and mitochondrial disease research[4].
• Lactic Dehydrogenase Activity in Blood. (1955) established LDH as a practical diagnostic enzyme with measurement methods and interpretive frameworks, enabling clinical monitoring of tissue injury and metabolic status. Its biochemistry-to-clinical link catalyzed widespread use of enzymatic biomarkers and shaped diagnostics for decades[5].
• Red Cell Metabolism: A Manual of Biochemical Methods. (1971) provided a comprehensive, standardized manual of biochemical methods for studying erythrocyte metabolism, catalyzing reproducible experiments, teaching, and large-scale metabolic investigations. Its methodological clarity became a lasting benchmark in lab protocols[6].
• The Biology of Human Starvation (1951) is a landmark synthesis of metabolic and physiological responses to prolonged starvation, detailing energy balance, substrate shifts, and organ adaptation. It transformed nutrition science, shaping clinical guidelines and fueling decades of research on metabolic resilience[7].

1980–1986

P450-Linked Redox Hepatic Metabolism

Contemporary themes

Oxidative stress and lipid peroxidation emerged as pervasive modulators of hepatic metabolism, linking redox signaling with lipid oxidation and hydroxyl radical pathways across hepatocytes, microsomes, and systemic models, with cytochrome P450 systems playing a central coordinating role. Regulation of carbohydrate flux through fructose-2,6-bisphosphate and related enzymes highlighted hormonal and allosteric tuning of glycolysis and gluconeogenesis in rat liver and isolated hepatocytes. Diet-driven adaptation and lipid handling, including peroxisomal beta-oxidation induction by high-fat diets, illustrated metabolic plasticity in hepatic lipid metabolism.

• Oxidative stress and lipid peroxidation emerged as pervasive modulators of hepatic metabolism, linking redox signaling with lipid oxidation and radical chemistry across hepatocytes, microsomes, and systemic models[1][3][5][8][10][18][19].
• Regulatory control of carbohydrate flux through fructose-2,6-bisphosphate and related enzymes emphasizes hormonal and allosteric tuning of glycolysis and gluconeogenesis, spanning rat liver and isolated hepatocytes[2][11][13][17][20].
• Cytochrome P450 systems and associated redox biology anchor hepatic metabolic regulation, with characterizations of P-450 forms, monooxygenase activity, and hydroxyl radical pathways linking metabolism to oxidative stress[1][4][8][10].
• Metabolic flux mapping and compartmentation methodologies provide cross-species insights into functional activity, enabling interpretation of liver and human metabolism via imaging and systemic-scale approaches[6][12][13].
• Diet-driven metabolic adaptation and lipid handling, including peroxisomal beta-oxidation induction by high-fat diets and lipid peroxidation outcomes, illustrate metabolic plasticity in hepatic lipid metabolism[3][5][16][18].

Influential works

• Multivalent feedback regulation of HMG CoA reductase, a control mechanism coordinating isoprenoid synthesis and cell growth. This work showed that multiple inputs, including sterols and isoprenoids, feedback to regulate the rate-limiting step of cholesterol synthesis, tying lipid production to cell growth and signaling.[5]
• The Metabolic Basis of Inherited Disease (1983) established a comprehensive framework uniting biochemistry, physiology, and clinical genetics to explain inherited metabolic disorders, shaping diagnosis, research priorities, and therapeutic perspectives for decades.[4]
• Homeostasis model assessment: insulin resistance and ?-cell function from fasting plasma glucose and insulin concentrations in man (1985) introduced HOMA, a simple mathematical model to estimate insulin resistance and beta-cell function from fasting measures, transforming population and clinical metabolism studies.[1]
• Effect of fatty acids on glucose production and utilization in man (1983) demonstrated that circulating fatty acids modulate hepatic gluconeogenesis and peripheral glucose uptake, revealing fuel-switching mechanisms critical to understanding metabolic flexibility in health and disease.[8]
• Lipid Peroxidation: Mechanisms, Analysis, Enzymology and Biological Relevance (1985) provided a comprehensive review of lipid peroxidation chemistry and biology, linking oxidative stress to membrane function and energy metabolism and catalyzing ongoing metabolic and aging research.[12]

1987–2004

Mitochondria-Driven Metabolic Signaling

Contemporary themes

During this period, metabolic research emphasized integrating mitochondrial signaling with whole-body energy homeostasis. Mitochondrial function and redox biology emerged as central regulators of metabolism and aging through reactive oxygen species signaling, biogenesis, and membrane dynamics. Adipose-derived signals such as leptin and adiponectin coordinated energy balance and lipid metabolism, while transcriptional control by PGC-1 and SREBP-1 unified tissue-wide metabolic regulation and lipid flux across organelles.

• Theme 1: Mitochondrial function and redox biology regulate core metabolism and aging, driven by reactive oxygen species signaling, mitochondrial biogenesis, and membrane permeabilization processes[1][4][5][8][13][15].
• Theme 2: Adipose-derived signaling—leptin and adiponectin—rules systemic energy balance and lipid metabolism, integrating adipokine biology with insulin responsiveness and obesity-related regulation[2][7][12][18][19].
• Theme 3: Transcriptional and pathway-level control of metabolism emphasizes transcriptional coactivators and systemic models, e.g., peroxisome proliferator-activated receptor gamma coactivator 1 (PGC-1), sterol regulatory element-binding protein 1 (SREBP-1), and metabolic-pathway theory, to explain regulation across tissues[5][6][7][10][14].
• Theme 4: Lipid metabolism and oxidation across organelles underpin energy homeostasis and metabolic disease, linking beta-oxidation, fatty acid synthesis regulation, and adipose-derived signals in obesity and metabolic syndrome[7][16][19][20].

Influential works

Foundational studies defined new paradigms: The Metabolic Basis of Inherited Disease linked genetic blocks to clinical phenotypes, catalyzing diagnostic genetics and systems biology. Leptin and the regulation of body weight in mammals established adiposity signaling as a hormonal axis between energy stores and appetite. Mechanisms Controlling Mitochondrial Biogenesis and Respiration through the Thermogenic Coactivator PGC-1 and the sterol regulatory element-binding proteins (SREBP-1) identified master regulators of mitochondrial biogenesis and hepatic lipid synthesis, reframing metabolism and metabolic syndrome. Reactive Oxygen Species: Metabolism, Oxidative Stress, and Signal Transduction synthesized redox signaling into core metabolic theory.

• The Metabolic Basis of Inherited Disease (1988) established a comprehensive framework linking genetic defects to specific enzymatic blocks and clinical phenotypes, catalyzing modern diagnostic genetics and systems biology approaches.[9]
• Leptin and the regulation of body weight in mammals (1998) introduced leptin as a hormonal signal of adiposity, revealing a feedback axis that links energy stores to appetite and metabolism, reshaping obesity research and endocrine-metabolic paradigms.[4]
• Mechanisms Controlling Mitochondrial Biogenesis and Respiration through the Thermogenic Coactivator PGC-1 (1999) identified PGC-1 as a master regulator of mitochondrial biogenesis and oxidative metabolism, guiding subsequent work on energy balance and metabolic diseases.[14]
• SREBPs: activators of the complete program of cholesterol and fatty acid synthesis in the liver (2002) defined sterol regulatory element-binding proteins as central transcriptional drivers of lipid synthesis, shaping research on hepatic metabolism and metabolic syndrome.[7]
• Reactive Oxygen Species: Metabolism, Oxidative Stress, and Signal Transduction (2004) synthesized how ROS integrate metabolism with redox signaling, highlighting oxidative stress in normal physiology and disease, informing antioxidant strategies.[1]

2005–2011

Sirtuin-Driven Metabolic Remodeling

Contemporary themes

Across 2005–2011, mitochondrial function emerged as the central regulator of energy stress responses. Research linked hypoxic signaling (hypoxia-inducible factor-1), pyruvate dehydrogenase kinase shifts, and AMP-activated protein kinase sensing to reprogram fuel use and mitochondrial output, with SIRT1/PGC-1α driving adaptive biogenesis and fatty acid oxidation. Parallel work positioned SIRT1 and SIRT3 as core mediators translating energy restriction into systemic remodeling, tying NAD+-dependent deacetylation to hepatic control, adiposity, and oxidative metabolism.

• Metabolic adaptation to energy stress centers on mitochondrial respiration as a regulatory hub, integrating hypoxic signaling (HIF-1) with PDHK shifts, AMPK sensing, and downstream SIRT1/PGC-1α axes to reprogram fuel usage and mitochondrial output under stress[1][2][8][3][9][5][7].
• Sirtuin family activity, especially SIRT1 and SIRT3, emerges as a core mechanism translating energy restriction into metabolic remodeling. NAD+-dependent deacetylation modulates PGC-1α, fatty acid oxidation, and mitochondrial efficiency, with pharmacological mimetics (resveratrol, fasting) reinforcing fat oxidation and hepatic metabolic control[3][9][10][12][13].
• The metabolic syndrome concept consolidates obesity-related dyslipidemia, insulin resistance, and altered adipose physiology into a common syndrome with metabolic health implications. Large definitional work coexists with studies of brown fat activity, UCP1 thermogenesis, and branched-chain amino acid signatures linking adiposity to insulin resistance[4][6][18][19][14][20].
• ROS generation and redox regulation within mitochondria are portrayed as signaling determinants of metabolic fate, where ROS biogenesis and mitochondrial redox metabolism interface with glycolysis, energy balance, and inflammatory signaling in disease contexts[16][17][11][20].
• p53-mediated regulation of metabolism encompasses mitochondrial respiration, glycolytic repression, and TIGAR-driven redirection of glucose flux, illustrating a tumor suppressor–metabolism axis that shapes cellular energy strategy under stress[5][7][11].

Influential works

Influential studies reframed metabolic syndrome as a redox- and mitochondria-centered condition, guiding risk assessment and interventions. Foundational consensus statements established global criteria and harmonized definitions, spurring cross-national epidemiology and guideline updates. Breakthrough demonstrations that resveratrol activates SIRT1 and PGC-1α to improve mitochondrial function linked polyphenols to metabolic health, catalyzing a broader push toward NAD+-dependent strategies and therapeutic mimetics.

• 'Diagnosis and Management of the Metabolic Syndrome' (2005)[4] formalized practical diagnostic criteria and risk management guidelines, catalyzing clinical adoption and shaping research priorities in prevention and treatment.
• 'Metabolic syndrome—a new world-wide definition. A Consensus Statement from the International Diabetes Federation' (2006)[12] provided a global consensus definition, harmonizing criteria across populations and spurring cross-national epidemiology, guideline updates, and policy.
• 'Harmonizing the Metabolic Syndrome' (2009)[10] offered a synthesis to reconcile divergent definitions, highlighting shared pathophysiology and guiding standardized research and clinical practice.
• 'How mitochondria produce reactive oxygen species' (2008)[2] dissected mitochondrial ROS generation mechanisms, reframing metabolic disease as a redox biology problem and directing antioxidant research.
• 'Resveratrol Improves Mitochondrial Function and Protects against Metabolic Disease by Activating SIRT1 and PGC-1α' (2006)[5] demonstrated a small molecule activating mitochondrial biogenesis pathways, linking polyphenols to metabolic improvement and inspiring drug/nutrition research.

2012–2024

Redox-Driven Metabolic Remodeling

Contemporary themes

During 2012-2024, metabolism research emphasized system-wide reprogramming in cancer and immunity, viewing metabolic changes as modular network shifts that couple tumor growth with immunometabolism and cell fate. Reactive oxygen species homeostasis and redox balance emerged as central regulators, linking mitochondrial ROS, iron-catalyzed lipid oxidation, and ferroptosis to cancer and metabolic disease. NAD+/NADPH flux and redox cofactor compartmentalization were identified as core drivers of remodeling across cancer and immune contexts, with NAD precursors and Nrf2-driven anabolism shaping fluxes and lipid signaling guiding energy allocation between lipogenesis and fatty acid oxidation.

• System-wide reprogramming of metabolism in cancer and immunity, framing metabolic changes as modular network shifts that link tumor growth, immunometabolism, and cell fate. Evidence spans cancer metabolism hallmarks, transcriptional-metabolic modules, and T cell checkpoints[1][4][5][15][16][19][20].
• ROS and redox balance emerge as central regulators of cell fate, linking mitochondrial ROS, iron-catalyzed oxidation, lipid peroxidation and ferroptosis with cancer and metabolic disease[8][9][11][12][14][18].
• NAD+/NADPH flux and redox cofactor compartmentalization underpin metabolic remodeling across cancer and immune contexts, with nicotinamide adenine dinucleotide precursors and Nrf2-driven anabolism shaping fluxes[2][6][7][19].
• Lipid metabolism and lipid signaling determine energy allocation via lipogenesis vs fatty acid oxidation, shaping hepatic metabolism, obesity and ferroptosis-linked pathways[8][10][11][17][18].

Influential works

Foundational work on reactive oxygen species as signaling mediators reframed redox biology within metabolism, inflammation, and aging. The discovery and conceptualization of ferroptosis as an iron-dependent lipid-peroxidation-driven cell death created a new regulatory layer for metabolic disease and cancer. Parallel advances linked gut microbiota–generated short-chain fatty acids to host energy and immune signaling, while curated metabolic pathway databases propelled systems biology and cross-species analyses.

• Reactive oxygen species homeostasis and redox regulation in cellular signaling (2012)[2] introduced the ROS signaling paradigm, detailing how Reactive Oxygen Species act as messengers within redox networks, shifting the view of oxidative stress from purely damaging to integral in metabolism, inflammation, and aging; long-lasting methodological frameworks and cross-disciplinary influence.
• Ferroptosis: Death by Lipid Peroxidation (2016)[3] defined ferroptosis as an iron-dependent, non-apoptotic cell death driven by lipid peroxidation, uncovering a new regulome of metabolism and oxidative damage; catalyzed surges in cancer and neurodegeneration research and therapeutic exploration.
• Formation of short chain fatty acids by the gut microbiota and their impact on human metabolism (2016)[9] revealed how gut microbes generate short chain fatty acids (SCFAs) like acetate, propionate, and butyrate, linking microbial metabolism to host energy, glucose homeostasis, and immune signaling via receptors and epigenetic mechanisms; a keystone in microbiome-metabolism research.
• MAFLD: A Consensus-Driven Proposed Nomenclature for Metabolic Associated Fatty Liver Disease (2020)[13] proposed MAFLD nomenclature to better reflect metabolic underpinnings, enabling global consensus and harmonization of epidemiology and research priorities; its adoption reshaped clinical framing and disease classification.
• The MetaCyc database of metabolic pathways and enzymes and the BioCyc collection of pathway/genome databases (2015)[15] delivered a comprehensive, curated, open-access metabolic pathways resource, catalyzing systems biology and computational modeling by enabling pathway-centric analyses and cross-species comparisons.